 BOSTON and JERUSALEM, March 11, 2021 GLOBE NEWSWIRE -- Entera Bio Ltd. NASDAQ: ENTX, a leader in the development of orally delivered large molecule therapeutics, announced it will report business and financial results for the year ended December 30, 2020 on March 18, 2021, before the U.S. financial markets open. 